PCN95 COST-EFFECTIVENESS ANALYSIS OF GERMLINE BRCA MUTATION TESTING AND OLAPARIB TREATMENT IN METASTATIC BREAST CANCER: AN EVALUATION OF CODEPENDENT TECHNOLOGIES

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.292
https://www.valueinhealthjournal.com/article/S1098-3015(19)32670-1/fulltext
Title : PCN95 COST-EFFECTIVENESS ANALYSIS OF GERMLINE BRCA MUTATION TESTING AND OLAPARIB TREATMENT IN METASTATIC BREAST CANCER: AN EVALUATION OF CODEPENDENT TECHNOLOGIES
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32670-1&doi=10.1016/j.jval.2019.09.292
First page :
Section Title :
Open access? : No
Section Order : 10233
Categories :
Tags :
Regions :
ViH Article Tags :